| scholarly article | Q13442814 |
| P2093 | author name string | Stacy D Brown | |
| Brooks B Pond | |||
| Robert Keasling | |||
| Jacob R Peters | |||
| P2860 | cites work | Synthesis, full chemical characterisation and development of validated methods for the quantification of (±)-4'-methylmethcathinone (mephedrone): a new "legal high" | Q84379066 |
| Elucidation of the Phase I and Phase II metabolic pathways of (±)-4'-methylmethcathinone (4-MMC) and (±)-4'-(trifluoromethyl)methcathinone (4-TFMMC) in rat liver hepatocytes using LC-MS and LC-MS² | Q84981114 | ||
| Mephedrone (methylmethcathinone) in toxicology casework: a Northern Ireland perspective | Q85963858 | ||
| Chiral separation of new cathinone- and amphetamine-related designer drugs by gas chromatography-mass spectrometry using trifluoroacetyl-l-prolyl chloride as chiral derivatization reagent | Q87432209 | ||
| Emerging drugs of abuse | Q87442801 | ||
| Testing for designer stimulants: metabolic profiles of 16 synthetic cathinones excreted free in human urine | Q87518537 | ||
| The toxicology of bath salts: a review of synthetic cathinones | Q28253719 | ||
| Toxicological determination and in vitro metabolism of the designer drug methylenedioxypyrovalerone (MDPV) by gas chromatography/mass spectrometry and liquid chromatography/quadrupole time-of-flight mass spectrometry | Q28292326 | ||
| Studies on the metabolism of the α-pyrrolidinophenone designer drug methylenedioxy-pyrovalerone (MDPV) in rat and human urine and human liver microsomes using GC-MS and LC-high-resolution MS and its detectability in urine by GC-MS | Q28297761 | ||
| Metabolomic analysis of rat brain by high resolution nuclear magnetic resonance spectroscopy of tissue extracts | Q28547044 | ||
| 3,4-Methylenedioxypyrovalerone (MDPV) and metabolites quantification in human and rat plasma by liquid chromatography-high resolution mass spectrometry | Q34115248 | ||
| Clinical experience with and analytical confirmation of "bath salts" and "legal highs" (synthetic cathinones) in the United States | Q34206558 | ||
| Prevalence of new psychoactive substances: A retrospective study in hair | Q34270004 | ||
| Analysis of synthetic cathinones commonly found in bath salts in human performance and postmortem toxicology: method development, drug distribution and interpretation of results | Q34325173 | ||
| Simultaneous determination of 40 novel psychoactive stimulants in urine by liquid chromatography-high resolution mass spectrometry and library matching | Q34474547 | ||
| Quantitative determination of d- and l-threo enantiomers of methylphenidate in brain tissue by liquid chromatography-mass spectrometry | Q34787453 | ||
| Dynamics of extracellular dopamine in the acute and chronic actions of cocaine | Q34795509 | ||
| Comprehensive review of the detection methods for synthetic cannabinoids and cathinones | Q35917163 | ||
| Quantitative bioanalytical methods validation and implementation: best practices for chromatographic and ligand binding assays | Q36801534 | ||
| Bath salts and synthetic cathinones: an emerging designer drug phenomenon | Q37540813 | ||
| Mephedrone: Public health risk, mechanisms of action, and behavioral effects. | Q38114258 | ||
| Designer cathinones--an emerging class of novel recreational drugs | Q38124509 | ||
| Three fatal intoxications due to methylone | Q40286882 | ||
| Thermal Degradation of Synthetic Cathinones: Implications for Forensic Toxicology | Q40620922 | ||
| "Bath salts"-induced psychosis in a young woman | Q40935223 | ||
| Mephedrone (4-methylmethcathinone)-related deaths | Q42744621 | ||
| Mephedrone: still available and twice the price | Q42833281 | ||
| Determination of a new designer drug, N-hydroxy-3,4-methylenedioxymethamphetamine and its metabolites in rats using ultra-performance liquid chromatography-tandem mass spectrometry | Q43124808 | ||
| Fatal mephedrone intoxication--a case report | Q45067994 | ||
| Deaths involving methylenedioxypyrovalerone (MDPV) in Upper East Tennessee | Q45120474 | ||
| Postmortem tissue distribution of MDPV following lethal intoxication by "bath salts". | Q46004696 | ||
| Development of gas chromatography-mass spectrometry (GC-MS) and other rapid screening methods for the analysis of 16 'legal high' cathinone derivatives | Q46917407 | ||
| Detection and quantification of new designer drugs in human blood: Part 1 - Synthetic cannabinoids. | Q47752093 | ||
| Analysis of 4-MEC in biological and non-biological material--three case reports | Q50056262 | ||
| "Bath salts" intoxication. | Q55054846 | ||
| Determination of cathinones and related ephedrines in forensic whole-blood samples by liquid-chromatography–electrospray tandem mass spectrometry | Q56767430 | ||
| The twilight of dementia | Q57725172 | ||
| Systematic evaluation of matrix effects in hydrophilic interaction chromatography versus reversed phase liquid chromatography coupled to mass spectrometry | Q62683833 | ||
| The effects of sample preparation methods on the variability of the electrospray ionization response for model drug compounds | Q78004126 | ||
| The disposition into hair of new designer drugs; methylone, MBDB and methcathinone | Q80553540 | ||
| Schedules of controlled substances: temporary placement of three synthetic cathinones in Schedule I. Final Order | Q82131955 | ||
| Synthesis, full chemical characterisation and development of validated methods for the quantification of the components found in the evolved "legal high" NRG-2 | Q82954437 | ||
| P433 | issue | 9 | |
| P304 | page(s) | 718-725 | |
| P577 | publication date | 2016-07-29 | |
| P1433 | published in | Journal of Analytical Toxicology | Q1709826 |
| P1476 | title | Quantification of Synthetic Cathinones in Rat Brain Using HILIC-ESI-MS/MS. | |
| P478 | volume | 40 |
Search more.